412 related articles for article (PubMed ID: 22541833)
21. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
Urban M; Pirk J; Dorazilova Z; Netuka I
Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
[TBL] [Abstract][Full Text] [Related]
22. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
[TBL] [Abstract][Full Text] [Related]
23. Temporal trends and outcomes of patients waiting on left ventricular assist devices and inotropes for heart transplantation.
Briasoulis A; Adegbala O; Akintoye E; Alvarez P
Clin Transplant; 2020 Jun; 34(6):e13857. PubMed ID: 32167606
[TBL] [Abstract][Full Text] [Related]
24. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
[TBL] [Abstract][Full Text] [Related]
25. Heart transplantation 1985-1998: 13-years experience at Angelo De Gasperis Cardio-Thoracic Department-Milan.
Colombo T; Vitali E; Lanfranconi M; Russo C; Bruschi G; Marchetti C; Colucci V; Frigerio M; Oliva F; Grassi M; Gronda E; Merli M; Pellegrini A
Clin Transpl; 1998; ():315-25. PubMed ID: 10503110
[TBL] [Abstract][Full Text] [Related]
26. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
[TBL] [Abstract][Full Text] [Related]
27. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
[TBL] [Abstract][Full Text] [Related]
28. Decline in heart transplant wait list mortality in the United States following broader regional sharing of donor hearts.
Singh TP; Almond CS; Taylor DO; Graham DA
Circ Heart Fail; 2012 Mar; 5(2):249-58. PubMed ID: 22247484
[TBL] [Abstract][Full Text] [Related]
29. Should stable UNOS Status 2 patients be transplanted?
Jimenez J; Bennett Edwards L; Higgins R; Bauerlein J; Pham S; Mallon S
J Heart Lung Transplant; 2005 Feb; 24(2):178-83. PubMed ID: 15701434
[TBL] [Abstract][Full Text] [Related]
30. The UNOS OPTN waiting list: 1988 to 1994. United Network for Organ Sharing. Organ Procurement and Transplantation Network.
Guo TJ; Daily OP; Davies DB
Clin Transpl; 1994; ():69-86. PubMed ID: 7547588
[TBL] [Abstract][Full Text] [Related]
31. Trends in the Use of Inotropes to List Adult Heart Transplant Candidates at Status 1A.
Parker WF; Garrity ER; Fedson S; Churpek MM
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29246896
[TBL] [Abstract][Full Text] [Related]
32. Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation.
Hsich EM; Blackstone EH; Thuita L; McNamara DM; Rogers JG; Ishwaran H; Schold JD
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611123
[TBL] [Abstract][Full Text] [Related]
33. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
[TBL] [Abstract][Full Text] [Related]
34. The UNOS OPTN (Organ Procurement and Transplantation Network) waiting list: 1988 through November 30, 1992.
Edwards EB; Breen TJ; Guo T; Ellison MD; Daily OP
Clin Transpl; 1992; ():61-75. PubMed ID: 1306723
[TBL] [Abstract][Full Text] [Related]
35. Temporary left ventricular assist devices as a bridge to heart transplantation.
Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
[TBL] [Abstract][Full Text] [Related]
36. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
[TBL] [Abstract][Full Text] [Related]
37. Bridge to heart transplantation with left ventricular assist device versus inotropic agents in status 1 patients.
Sasaki H; Mitchell JD; Jessen ME; Lavingia B; Kaiser PA; Comeaux A; Dimaio JM; Meyer DM
J Card Surg; 2009; 24(6):756-62. PubMed ID: 19754680
[TBL] [Abstract][Full Text] [Related]
38. Stable patients on left ventricular assist device support have a disproportionate advantage: time to re-evaluate the current UNOS policy.
Moazami N; Sun B; Feldman D
J Heart Lung Transplant; 2011 Sep; 30(9):971-4. PubMed ID: 21676630
[TBL] [Abstract][Full Text] [Related]
39. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of risk indices in continuous-flow left ventricular assist device patients.
Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
